Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Review Article

A Review on Computational Analysis of Big Data in Breast Cancer for Predicting Potential Biomarkers

Author(s): Nilofer Shaikh, Sanket Bapat, Muthukumarasamy Karthikeyan and Renu Vyas*

Volume 22, Issue 21, 2022

Published on: 26 September, 2022

Page: [1793 - 1810] Pages: 18

DOI: 10.2174/1568026622666220907121942

Price: $65

Abstract

Breast cancer is the most predominantly occurring cancer in the world. Several genes and proteins have been recently studied to predict biomarkers that enable early disease identification and monitor its recurrence. In the era of high-throughput technology, studies show several applications of big data for identifying potential biomarkers. The review aims to provide a comprehensive overview of big data analysis in breast cancer towards the prediction of biomarkers with emphasis on computational methods like text mining, network analysis, next-generation sequencing technology (NGS), machine learning (ML), deep learning (DL), and precision medicine. Integrating data from various computational approaches enables the stratification of cancer patients and the identification of molecular signatures in cancer and their subtypes. The computational methods and statistical analysis help expedite cancer prognosis and develop precision cancer medicine (PCM). As a part of case study in the present work, we constructed a large gene-drug interaction network to predict new biomarkers genes. The gene-drug network helped us to identify eight genes that could serve as novel potential biomarkers.

Keywords: Breast cancer, biomarkers, big data, text mining, network analysis, driver genes.

« Previous
Graphical Abstract

[1]
Waks, A.G.; Winer, E.P. Breast cancer treatment: A review. JAMA, 2019, 321, 288-300.
[http://dx.doi.org/10.1001/jama.2018.19323]
[2]
Lüönd, F.; Tiede, S.; Christofori, G. Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression. Br. J. Cancer, 2021, 125(2), 164-175.
[http://dx.doi.org/10.1038/s41416-021-01328-7] [PMID: 33824479]
[3]
Heer, E.; Harper, A.; Escandor, N.; Sung, H.; McCormack, V.; Fidler-Benaoudia, M.M. Global burden and trends in premenopausal and postmenopausal breast cancer: A population-based study. Lancet Glob. Health, 2020, 8(8), e1027-e1037.
[http://dx.doi.org/10.1016/S2214-109X(20)30215-1] [PMID: 32710860]
[4]
Lei, S.; Zheng, R.; Zhang, S.; Wang, S.; Chen, R.; Sun, K.; Zeng, H.; Zhou, J.; Wei, W. Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020. Cancer Commun. (Lond.), 2021, 41(11), 1183-1194.
[http://dx.doi.org/10.1002/cac2.12207] [PMID: 34399040]
[5]
Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 2021, 71(3), 209-249.
[http://dx.doi.org/10.3322/caac.21660] [PMID: 33538338]
[6]
Bhattacharyya, G.S.; Doval, D.C.; Desai, C.J.; Chaturvedi, H.; Sharma, S.; Somashekhar, S.P. Overview of breast cancer and implications of overtreatment of early-stage breast cancer: An Indian perspective. JCO Glob. Oncol., 2020, 6(6), 789-798.
[http://dx.doi.org/10.1200/GO.20.00033] [PMID: 32511068]
[7]
Yilmaz, T.U.; Trabzonlu, L.; Güler, S.A.; Baran, M.A.; Pösteki, G.; Erçin, C.; Utkan, Z. Characteristics of special type breast tumors in our center. Eur. J. Breast Health, 2018, 14(1), 17-22.
[http://dx.doi.org/10.5152/ejbh.2017.3219] [PMID: 29322114]
[8]
McCart Reed, A.E.; Kutasovic, J.R.; Nones, K.; Saunus, J.M.; Da Silva, L.; Newell, F.; Kazakoff, S.; Melville, L.; Jayanthan, J.; Vargas, A.C.; Reid, L.E.; Beesley, J.; Chen, X.Q.; Patch, A.M.; Clouston, D.; Porter, A.; Evans, E.; Pearson, J.V.; Chenevix-Trench, G.; Cummings, M.C.; Waddell, N.; Lakhani, S.R.; Simpson, P.T. Mixed ductal-lobular carcinomas: Evidence for progression from ductal to lobular morphology. J. Pathol., 2018, 244(4), 460-468.
[http://dx.doi.org/10.1002/path.5040] [PMID: 29344954]
[9]
Salvatorelli, L.; Puzzo, L.; Vecchio, G.M.; Caltabiano, R.; Virzì, V.; Magro, G. Ductal carcinoma in situ of the breast: An update with emphasis on radiological and morphological features as predictive prognostic factors. Cancers (Basel), 2020, 12(3), 609.
[http://dx.doi.org/10.3390/cancers12030609] [PMID: 32155777]
[10]
Dettogni, R.S.; Stur, E.; Laus, A.C.; da Costa Vieira, R.A.; Marques, M.M.C.; Santana, I.V.V.; Pulido, J.Z.; Ribeiro, L.F.; de Jesus Parmanhani, N.; Agostini, L.P.; dos Reis, R.S.; de Vargas Wolfgramm dos Santos, E.; Alves, L.N.R.; Garcia, F.M.; Santos, J.A.; do Prado Ventorim, D.; Reis, R.M.; Louro, I.D. Potential biomarkers of ductal carcinoma in situ progression. BMC Cancer, 2020, 20(1), 119.
[http://dx.doi.org/10.1186/s12885-020-6608-y] [PMID: 32050925]
[11]
Dai, X.; Xiang, L.; Li, T.; Bai, Z. Cancer hallmarks, biomarkers and breast cancer molecular subtypes. J. Cancer, 2016, 7(10), 1281-1294.
[http://dx.doi.org/10.7150/jca.13141] [PMID: 27390604]
[12]
Shee, K.; Muller, K.E.; Marotti, J.; Miller, T.W.; Wells, W.A.; Tsongalis, G.J. Ductal carcinoma in situ biomarkers in a precision medicine era. Am. J. Pathol., 2019, 189(5), 956-965.
[http://dx.doi.org/10.1016/j.ajpath.2018.08.020] [PMID: 30385093]
[13]
Wang, D.Y.; Jiang, Z.; Ben-David, Y.; Woodgett, J.R.; Zacksenhaus, E. Molecular stratification within triple-negative breast cancer subtypes. Sci. Rep., 2019, 9(1), 19107.
[http://dx.doi.org/10.1038/s41598-019-55710-w] [PMID: 31836816]
[14]
Liu, Y.X.; Zhang, K.J.; Tang, L.L. Clinical significance of androgen receptor expression in triple negative breast cancer-an immunohistochemistry study. Oncol. Lett., 2018, 15(6), 10008-10016.
[http://dx.doi.org/10.3892/ol.2018.8548] [PMID: 29844843]
[15]
Acheampong, T.; Kehm, R.D.; Terry, M.B.; Argov, E.L.; Tehranifar, P. Incidence trends of breast cancer molecular subtypes by age and race/ethnicity in the US from 2010 to 2016. JAMA Netw. Open, 2020, 3(8), e2013226.
[http://dx.doi.org/10.1001/jamanetworkopen.2020.13226] [PMID: 32804214]
[16]
Shen, G.; Zhao, F.; Huo, X.; Ren, D.; Du, F.; Zheng, F.; Zhao, J. Meta-analysis of HER2-enriched subtype predicting the pathological complete response within HER2-positive breast cancer in patients who received neoadjuvant treatment. Front. Oncol., 2021, 11, 632357.
[http://dx.doi.org/10.3389/fonc.2021.632357] [PMID: 34367947]
[17]
Yersal, O.; Barutca, S. Biological subtypes of breast cancer: Prognostic and therapeutic implications. World J. Clin. Oncol., 2014, 5(3), 412-424.
[http://dx.doi.org/10.5306/wjco.v5.i3.412] [PMID: 25114856]
[18]
Zarotti, C.; Papassotiropoulos, B.; Elfgen, C.; Dedes, K.; Vorburger, D.; Pestalozzi, B.; Trojan, A.; Varga, Z. Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy. Sci. Rep., 2022, 12(1), 91.
[http://dx.doi.org/10.1038/s41598-021-04032-x] [PMID: 34997055]
[19]
Nguyen, Q.H.; Nguyen, H.; Nguyen, T.; Le, D.H. Multi-omics analysis detects novel prognostic subgroups of breast cancer. Front. Genet., 2020, 11, 574661.
[http://dx.doi.org/10.3389/fgene.2020.574661] [PMID: 33193681]
[20]
Weigel, M.T.; Dowsett, M. Current and emerging biomarkers in breast cancer: Prognosis and prediction. Endocr. Relat. Cancer, 2010, 17(4), R245-R262.
[http://dx.doi.org/10.1677/ERC-10-0136] [PMID: 20647302]
[21]
Schick, J.; Ritchie, R.P.; Restini, C. Breast cancer therapeutics and biomarkers: Past, present, and future approaches. Breast Cancer (Auckl.), 2021, 15, 1178223421995854.
[http://dx.doi.org/10.1177/1178223421995854] [PMID: 33994789]
[22]
Li, C.J.; Chen, H.M.; Lai, J.C. Diagnostic, prognostic, and predictive biomarkers in breast cancer. J. Oncol., 2020, 2020, 1835691.
[http://dx.doi.org/10.1155/2020/1835691] [PMID: 32256579]
[23]
Ades, F.; Tryfonidis, K.; Zardavas, D. The past and future of breast cancer treatment - from the Papyrus to individualised treatment approaches. Ecancermedicalscience, 2017, 11, 746.
[24]
Wang, J.; Xu, B. Targeted therapeutic options and future perspectives for HER2-positive breast cancer. Signal Transduct. Target. Ther., 2019, 4(1), 34.
[http://dx.doi.org/10.1038/s41392-019-0069-2] [PMID: 31637013]
[25]
Masoud, V.; Pagès, G. Targeted therapies in breast cancer: New challenges to fight against resistance. World J. Clin. Oncol., 2017, 8(2), 120-134.
[http://dx.doi.org/10.5306/wjco.v8.i2.120] [PMID: 28439493]
[26]
Tong, C.W.S.; Wu, M.; Cho, W.C.S.; To, K.K.W. Recent advances in the treatment of breast cancer. Front. Oncol., 2018, 8, 227.
[http://dx.doi.org/10.3389/fonc.2018.00227] [PMID: 29963498]
[27]
Incorvati, J.A.; Shah, S.; Mu, Y.; Lu, J. Targeted therapy for HER2 positive breast cancer. J. Hematol. Oncol., 2013, 6(1), 38.
[http://dx.doi.org/10.1186/1756-8722-6-38] [PMID: 23731980]
[28]
Ju, J.; Zhu, A.J.; Yuan, P. Progress in targeted therapy for breast cancer. Chronic Dis. Transl. Med., 2018, 4(3), 164-175.
[http://dx.doi.org/10.1016/j.cdtm.2018.04.002] [PMID: 30276363]
[29]
Carlisle, J.W.; Harvey, R.D. Tyrosine kinase inhibitors, antibody-drug conjugates, and proteolysis-targeting chimeras: The pharmacology of cutting-edge lung cancer therapies. Am. Soc. Clin. Oncol. Educ. Book, 2021, 41(41), e286-e293.
[http://dx.doi.org/10.1200/EDBK_320667] [PMID: 34061559]
[30]
Wu, C.; Peng, S.; Pilié, P.G.; Geng, C.; Park, S.; Manyam, G.C.; Lu, Y.; Yang, G.; Tang, Z.; Kondraganti, S.; Wang, D.; Hudgens, C.W.; Ledesma, D.A.; Marques-Piubelli, M.L.; Torres-Cabala, C.A.; Curry, J.L.; Troncoso, P.; Corn, P.G.; Broom, B.M.; Thompson, T.C. PARP and CDK4/6 inhibitor combination therapy induces apoptosis and suppresses neuroendocrine differentiation in prostate cancer. Mol. Cancer Ther., 2021, 20(9), 1680-1691.
[http://dx.doi.org/10.1158/1535-7163.MCT-20-0848] [PMID: 34158347]
[31]
Murthy, P.; Muggia, F. PARP inhibitors: Clinical development, emerging differences, and the current therapeutic issues. Cancer Drug Resist., 2019, 2(3), 665-679.
[http://dx.doi.org/10.20517/cdr.2019.002] [PMID: 35582575]
[32]
Brown, T.A., II; Mittendorf, E.A.; Hale, D.F.; Myers, J.W., III; Peace, K.M.; Jackson, D.O.; Greene, J.M.; Vreeland, T.J.; Clifton, G.T.; Ardavanis, A.; Litton, J.K.; Shumway, N.M.; Symanowski, J.; Murray, J.L.; Ponniah, S.; Anastasopoulou, E.A.; Pistamaltzian, N.F.; Baxevanis, C.N.; Perez, S.A.; Papamichail, M.; Peoples, G.E. Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence. Breast Cancer Res. Treat., 2020, 181(2), 391-401.
[http://dx.doi.org/10.1007/s10549-020-05638-x] [PMID: 32323103]
[33]
Rasha, F.; Sharma, M.; Pruitt, K. Mechanisms of endocrine therapy resistance in breast cancer. Mol. Cell. Endocrinol., 2021, 532, 111322.
[http://dx.doi.org/10.1016/j.mce.2021.111322] [PMID: 34000350]
[34]
Du, L.; Yau, C.; Brown-Swigart, L.; Gould, R.; Krings, G.; Hirst, G.L.; Bedrosian, I.; Layman, R.M.; Carter, J.M.; Klein, M.; Venters, S.; Shad, S.; van der Noordaa, M.; Chien, A.J.; Haddad, T.; Isaacs, C.; Pusztai, L.; Albain, K.; Nanda, R.; Tripathy, D.; Liu, M.C.; Boughey, J.; Schwab, R.; Hylton, N.; DeMichele, A.; Perlmutter, J.; Yee, D.; Berry, D.; van’t Veer, L.; Valero, V.; Esserman, L.J.; Symmans, W.F. Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2−) breast cancer before chemo-endocrine therapy. Ann. Oncol., 2021, 32(5), 642-651.
[http://dx.doi.org/10.1016/j.annonc.2021.02.011] [PMID: 33617937]
[35]
Mester, J.; Redeuilh, G. Proliferation of breast cancer cells: Regulation, mediators, targets for therapy. Anticancer. Agents Med. Chem., 2008, 8(8), 872-885.
[http://dx.doi.org/10.2174/187152008786847747] [PMID: 19075570]
[36]
Chalakur-Ramireddy, N.K.R.; Pakala, S.B. Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer. Biosci. Rep., 2018, 38(1), BSR20171357.
[http://dx.doi.org/10.1042/BSR20171357] [PMID: 29298879]
[37]
Mir, M.A.; Qayoom, H.; Mehraj, U.; Nisar, S.; Bhat, B.; Wani, N.A. Targeting different pathways using novel combination therapy in triple negative breast cancer. Curr. Cancer Drug Targets, 2020, 20(8), 586-602.
[http://dx.doi.org/10.2174/1570163817666200518081955] [PMID: 32418525]
[38]
Li, Y.; Zhan, Z.; Yin, X.; Fu, S.; Deng, X. Targeted therapeutic strategies for triple-negative breast cancer. Front. Oncol., 2021, 11, 731535.
[http://dx.doi.org/10.3389/fonc.2021.731535] [PMID: 34778045]
[39]
Costa, R.L.B.; Czerniecki, B.J. Clinical development of immunotherapies for HER2+ breast cancer: A review of HER2-directed monoclonal antibodies and beyond. NPJ Breast Cancer, 2020, 6(1), 10.
[http://dx.doi.org/10.1038/s41523-020-0153-3] [PMID: 32195333]
[40]
Scott, A.M.; Allison, J.P.; Wolchok, J.D. Monoclonal antibodies in cancer therapy. Cancer Immun., 2012, 12, 14.
[PMID: 22896759]
[41]
Jin, S.; Sun, Y.; Liang, X.; Gu, X.; Ning, J.; Xu, Y.; Chen, S.; Pan, L. Emerging new therapeutic antibody derivatives for cancer treatment. Signal Transduct. Target. Ther., 2022, 7(1), 39.
[http://dx.doi.org/10.1038/s41392-021-00868-x] [PMID: 35132063]
[42]
Burstein, H.J.; Lacchetti, C.; Anderson, H.; Buchholz, T.A.; Davidson, N.E.; Gelmon, K.A.; Giordano, S.H.; Hudis, C.A.; Solky, A.J.; Stearns, V.; Winer, E.P.; Griggs, J.J. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO Clinical Practice Guideline Focused Update. J. Clin. Oncol., 2019, 37(5), 423-438.
[http://dx.doi.org/10.1200/JCO.18.01160] [PMID: 30452337]
[43]
Hsu, J.L.; Hung, M.C. The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer. Cancer Metastasis Rev., 2016, 35(4), 575-588.
[http://dx.doi.org/10.1007/s10555-016-9649-6] [PMID: 27913999]
[44]
Furrer, D.; Paquet, C.; Jacob, S.; Diorio, C. The human epidermal growth factor receptor 2 (HER2) as a prognostic and predictive biomarker: Molecular insights into HER2 activation and diagnostic implications. Mol. Biol. Int., 2014, 2014, 852748.
[45]
Rossanese, O.; Eccles, S.; Springer, C.; Swain, A.; Raynaud, F.I.; Workman, P.; Kirkin, V. The pharmacological audit trail (PhAT): Use of tumor models to address critical issues in the preclinical development of targeted anticancer drugs. Drug Discov. Today Dis. Models, 2016, 21, 23-32.
[http://dx.doi.org/10.1016/j.ddmod.2017.07.002]
[46]
Yee, L.M.; Lively, T.G.; McShane, L.M. Biomarkers in early-phase trials: Fundamental issues. Bioanalysis, 2018, 10(12), 933-944.
[http://dx.doi.org/10.4155/bio-2018-0006] [PMID: 29923753]
[47]
Lauschke, V.M.; Milani, L.; Ingelman-Sundberg, M. Pharmacogenomic Biomarkers for Improved Drug Therapy—Recent Progress and Future Developments. AAPS J., 2018, 20(1), 4.
[http://dx.doi.org/10.1208/s12248-017-0161-x] [PMID: 29181807]
[48]
Jackson, R.C. Pharmacodynamic modelling of biomarker data in oncology. ISRN Pharmacol., 2012, 2012, 590626.
[http://dx.doi.org/10.5402/2012/590626] [PMID: 22523699]
[49]
Li, X.; Zeng, Z.; Wang, J.; Wu, Y.; Chen, W.; Zheng, L.; Xi, T.; Wang, A.; Lu, Y. MicroRNA-9 and breast cancer. Biomed. Pharmacother., 2020, 122, 109687.
[http://dx.doi.org/10.1016/j.biopha.2019.109687] [PMID: 31918267]
[50]
Si, W.; Shen, J.; Zheng, H.; Fan, W. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin. Epigenetics, 2019, 11(1), 25.
[http://dx.doi.org/10.1186/s13148-018-0587-8] [PMID: 30744689]
[51]
Ghafouri-Fard, S.; Abak, A.; Shoorei, H.; Mohaqiq, M.; Majidpoor, J.; Sayad, A.; Taheri, M. Regulatory role of microRNAs on PTEN signaling. Biomed. Pharmacother., 2021, 133, 110986.
[http://dx.doi.org/10.1016/j.biopha.2020.110986] [PMID: 33166764]
[52]
Bhat, S.A.; Majid, S.; Hassan, T. MicroRNAs and its emerging role as breast cancer diagnostic marker- A review. Adv. Biomarker Sci. Technol., 2019, 1, 1-8.
[http://dx.doi.org/10.1016/j.abst.2019.05.001]
[53]
Rios-Colon, L.; Deep, G.; Kumar, D. Emerging role of microRNA 628-5p as a novel biomarker for cancer and other diseases. Tumour Biol., 2019, 41(10), 1010428319881344.
[http://dx.doi.org/10.1177/1010428319881344] [PMID: 31608792]
[54]
Wang, H.; Peng, R.; Wang, J.; Qin, Z.; Xue, L. Circulating microRNAs as potential cancer biomarkers: The advantage and disadvantage. Clin. Epigenetics, 2018, 10(1), 59.
[http://dx.doi.org/10.1186/s13148-018-0492-1] [PMID: 29713393]
[55]
Gao, J.J.; Swain, S.M.; Luminal, A.; Luminal, A. Breast Cancer and Molecular Assays: A Review. Oncologist, 2018, 23(5), 556-565.
[http://dx.doi.org/10.1634/theoncologist.2017-0535] [PMID: 29472313]
[56]
Puppe, J.; Seifert, T.; Eichler, C.; Pilch, H.; Mallmann, P.; Malter, W. Genomic signatures in luminal breast cancer. Breast Care (Basel), 2020, 15(4), 355-365.
[http://dx.doi.org/10.1159/000509846] [PMID: 32982645]
[57]
Ni, X.; Wan, W.; Ma, J.; Liu, X.; Zheng, B.; He, Z.; Yang, W.; Huang, L. A novel prognostic biomarker of luminal breast cancer: High CD39 expression is related to poor survival. Front. Genet., 2021, 12, 682503.
[http://dx.doi.org/10.3389/fgene.2021.682503] [PMID: 34220957]
[58]
Hamid, A.; Wang, X.V.; Chen, Y.H.; Feng, F.Y.; Den, R.B.; Attard, G.; Van Allen, E.M.; Huang, H.C.; Karns, A.; Dittamore, R.; Davicioni, E.; Liu, G.; DiPaola, R.S.; Carducci, M.A.; Sweeney, C.; Luminal, B. Luminal B subtype as a predictive biomarker of docetaxel benefit for newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC): A correlative study of E3805 CHAARTED. J. Clin. Oncol., 2020, 38(6)(Suppl.), 162.
[http://dx.doi.org/10.1200/JCO.2020.38.6_suppl.162]
[59]
Li, P.; Yuan, W.; Wu, R.; Zeng, C.; Li, K.; Lu, L. Androgens in patients with Luminal B and HER2 breast cancer might be a biomarker promoting Anti-PD-1 efficacy. Front. Oncol., 2022, 12, 917400.
[http://dx.doi.org/10.3389/fonc.2022.917400] [PMID: 35880165]
[60]
Lv, J.; Ren, J.; Zheng, J.; Zhang, F.; Han, M. Prognosis of tumor microenvironment in Luminal B-Type breast cancer. Dis. Markers, 2022, 2022, 5621441.
[http://dx.doi.org/10.1155/2022/5621441] [PMID: 35242245]
[61]
Jamshidi, N.; Yamamoto, S.; Gornbein, J.; Kuo, M.D. Receptor-based surrogate subtypes and discrepancies with breast cancer intrinsic subtypes: Implications for image biomarker development. Radiology, 2018, 289(1), 210-217.
[http://dx.doi.org/10.1148/radiol.2018171118] [PMID: 30040052]
[62]
Yadav, B.S.; Chanana, P.; Jhamb, S. Biomarkers in triple negative breast cancer: A review. World J. Clin. Oncol., 2015, 6(6), 252-263.
[http://dx.doi.org/10.5306/wjco.v6.i6.252] [PMID: 26677438]
[63]
Cocco, S.; Piezzo, M.; Calabrese, A.; Cianniello, D.; Caputo, R.; Di Lauro, V.; Fusco, G.; di Gioia, G.; Licenziato, M.; de Laurentiis, M. Biomarkers in triple-negative breast cancer: State-of-the-Art and future perspectives. Int. J. Mol. Sci., 2020, 21(13), 4579.
[http://dx.doi.org/10.3390/ijms21134579] [PMID: 32605126]
[64]
Liu, Y.; Teng, L.; Fu, S.; Wang, G.; Li, Z.; Ding, C.; Wang, H.; Bi, L. Highly heterogeneous-related genes of triple-negative breast cancer: Potential diagnostic and prognostic biomarkers. BMC Cancer, 2021, 21(1), 644.
[http://dx.doi.org/10.1186/s12885-021-08318-1] [PMID: 34053447]
[65]
Marra, A.; Trapani, D.; Viale, G.; Criscitiello, C.; Curigliano, G. Practical classification of triple-negative breast cancer: Intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies. NPJ Breast Cancer, 2020, 6(1), 54.
[http://dx.doi.org/10.1038/s41523-020-00197-2] [PMID: 33088912]
[66]
Chehade, R.; Awan, A.A.; Fernandes, R. A narrative review of biomarkers in advanced triple negative breast cancer. Precis. Cancer Med., 2021, 4, 24.
[http://dx.doi.org/10.21037/pcm-20-76]
[67]
Dieci, M.V.; Miglietta, F.; Griguolo, G.; Guarneri, V. Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors. Cancer Treat. Rev., 2020, 88, 102064.
[http://dx.doi.org/10.1016/j.ctrv.2020.102064] [PMID: 32622272]
[68]
Díaz-Gil, L.; Brasó-Maristany, F.; Locatelli, C.; Centa, A. Győrffy, B.; Ocaña, A.; Prat, A.; Pandiella, A. Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer. J. Exp. Clin. Cancer Res., 2021, 40(1), 313.
[http://dx.doi.org/10.1186/s13046-021-02098-z] [PMID: 34620206]
[69]
Martínez-Sáez, O.; Prat, A. Current and future management of HER2-Positive metastatic breast cancer. JCO Oncol. Pract., 2021, 17(10), 594-604.
[http://dx.doi.org/10.1200/OP.21.00172] [PMID: 34077236]
[70]
Zhou, X.; Xiao, C.; Han, T.; Qiu, S.; Wang, M.; Chu, J.; Sun, W.; Li, L.; Lin, L. Prognostic biomarkers related to breast cancer recurrence identified based on Logit model analysis. World J. Surg. Oncol., 2020, 18(1), 254.
[http://dx.doi.org/10.1186/s12957-020-02026-z] [PMID: 32977823]
[71]
Bao, C.; Lu, Y.; Chen, J.; Chen, D.; Lou, W.; Ding, B.; Xu, L.; Fan, W. Exploring specific prognostic biomarkers in triple-negative breast cancer. Cell Death Dis., 2019, 10(11), 807.
[http://dx.doi.org/10.1038/s41419-019-2043-x] [PMID: 31649243]
[72]
Abubakar, M.; Guo, C.; Koka, H.; Zhu, B.; Deng, J.; Hu, N.; Zhou, B.; Garcia-Closas, M.; Lu, N.; Yang, X.R. Impact of breast cancer risk factors on clinically relevant prognostic biomarkers for primary breast cancer. Breast Cancer Res. Treat., 2021, 189(2), 483-495.
[http://dx.doi.org/10.1007/s10549-021-06294-5] [PMID: 34185195]
[73]
Rakha, E.A.; Chmielik, E.; Schmitt, F.C.; Tan, P.H.; Quinn, C.M.; Gallagy, G. Assessment of predictive biomarkers in breast cancer: Challenges and updates; PAT, 2022. [Epub ahead of print]
[74]
Beelen, K.; Zwart, W.; Linn, S.C. Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy? Nat. Rev. Clin. Oncol., 2012, 9(9), 529-541.
[http://dx.doi.org/10.1038/nrclinonc.2012.121] [PMID: 22825374]
[75]
Jana, D.; Sarkar, D.K.; Ganguly, S.; Saha, S.; Sa, G.; Manna, A.K.; Banerjee, A.; Mandal, S. Role of Cyclooxygenase 2 (COX-2) in prognosis of breast cancer. Indian J. Surg. Oncol., 2014, 5(1), 59-65.
[http://dx.doi.org/10.1007/s13193-014-0290-y] [PMID: 24669166]
[76]
Xu, F.; Li, M.; Zhang, C.; Cui, J.; Liu, J.; Li, J.; Jiang, H. Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: A meta-analysis. Oncotarget, 2017, 8(4), 6003-6012.
[http://dx.doi.org/10.18632/oncotarget.13990] [PMID: 27999206]
[77]
Ortiz, A.B.; Garcia, D.; Vicente, Y.; Palka, M.; Bellas, C.; Martin, P. Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma. PLoS One, 2017, 12(11), e0188068.
[http://dx.doi.org/10.1371/journal.pone.0188068] [PMID: 29140993]
[78]
Tobin, N.P.; Sims, A.H.; Lundgren, K.L.; Lehn, S.; Landberg, G. Cyclin D1, Id1 and EMT in breast cancer. BMC Cancer, 2011, 11(1), 417.
[http://dx.doi.org/10.1186/1471-2407-11-417] [PMID: 21955753]
[79]
Afzal, S.; Hassan, M.; Ullah, S.; Abbas, H.; Tawakkal, F.; Khan, M.A. Breast Cancer; Discovery of novel diagnostic biomarkers, drug resistance, and therapeutic implications. Front. Mol. Biosci., 2022, 9, 783450.
[http://dx.doi.org/10.3389/fmolb.2022.783450] [PMID: 35265667]
[80]
Zubair, M.; Wang, S.; Ali, N. Advanced approaches to breast cancer classification and diagnosis. Front. Pharmacol., 2021, 11, 632079.
[http://dx.doi.org/10.3389/fphar.2020.632079] [PMID: 33716731]
[81]
Rossi, R.L.; Grifantini, R.M. Big data: Challenge and opportunity for translational and industrial research in healthcare. Front. Digit. Human., 2018, 5, 13.
[82]
Stark, G.F.; Hart, G.R.; Nartowt, B.J.; Deng, J. Predicting breast cancer risk using personal health data and machine learning models. PLoS One, 2019, 14(12), e0226765.
[http://dx.doi.org/10.1371/journal.pone.0226765] [PMID: 31881042]
[83]
Agrawal, R.; Prabakaran, S. Big data in digital healthcare: Lessons learnt and recommendations for general practice. Heredity, 2020, 124(4), 525-534.
[http://dx.doi.org/10.1038/s41437-020-0303-2] [PMID: 32139886]
[84]
Tsai, C.J.; Riaz, N.; Gomez, S.L. Big Data in Cancer Research: Real-world resources for precision oncology to improve cancer care delivery. Semin. Radiat. Oncol., 2019, 29(4), 306-310.
[http://dx.doi.org/10.1016/j.semradonc.2019.05.002] [PMID: 31472730]
[85]
Yang, Y.; Dong, X.; Xie, B.; Ding, N.; Chen, J.; Li, Y.; Zhang, Q.; Qu, H.; Fang, X. Databases and web tools for cancer genomics study. Genomics Proteomics Bioinformatics, 2015, 13(1), 46-50.
[http://dx.doi.org/10.1016/j.gpb.2015.01.005] [PMID: 25707591]
[86]
Sathyanarayanan, A.; Gupta, R.; Thompson, E.W.; Nyholt, D.R.; Bauer, D.C.; Nagaraj, S.H. A comparative study of multi-omics integration tools for cancer driver gene identification and tumour subtyping. Brief. Bioinform., 2020, 21(6), 1920-1936.
[http://dx.doi.org/10.1093/bib/bbz121] [PMID: 31774481]
[87]
Rohart, F.; Gautier, B.; Singh, A.; Lê Cao, K.A. mixOmics: An R package for ‘omics feature selection and multiple data integration. PLOS Comput. Biol., 2017, 13(11), e1005752.
[http://dx.doi.org/10.1371/journal.pcbi.1005752] [PMID: 29099853]
[88]
Tamborero, D.; Lopez-Bigas, N.; Gonzalez-Perez, A. Oncodrive-CIS: A method to reveal likely driver genes based on the impact of their copy number changes on expression. PLoS One, 2013, 8(2), e55489.
[http://dx.doi.org/10.1371/journal.pone.0055489] [PMID: 23408991]
[89]
Weinstein, J.N.; Collisson, E.A.; Mills, G.B.; Shaw, K.R.M.; Ozenberger, B.A.; Ellrott, K.; Shmulevich, I.; Sander, C.; Stuart, J.M. The cancer genome atlas pan-cancer analysis project. Nat. Genet., 2013, 45, 1113-1120.
[90]
ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature, 2020, 578(7793), 82-93.
[http://dx.doi.org/10.1038/s41586-020-1969-6] [PMID: 32025007]
[91]
Forbes, S.A.; Tang, G.; Bindal, N.; Bamford, S.; Dawson, E.; Cole, C.; Kok, C.Y.; Jia, M.; Ewing, R.; Menzies, A.; Teague, J.W.; Stratton, M.R.; Futreal, P.A. COSMIC (the Catalogue of Somatic Mutations in Cancer): A resource to investigate acquired mutations in human cancer. Nucleic Acids Res., 2010, 38(Suppl. 1), D652-D657.
[http://dx.doi.org/10.1093/nar/gkp995] [PMID: 19906727]
[92]
Rudnick, P.A.; Markey, S.P.; Roth, J.; Mirokhin, Y.; Yan, X.; Tchekhovskoi, D.V.; Edwards, N.J.; Thangudu, R.R.; Ketchum, K.A.; Kinsinger, C.R.; Mesri, M.; Rodriguez, H.; Stein, S.E. A description of the clinical proteomic tumor analysis consortium (CPTAC) common data analysis pipeline. J. Proteome Res., 2016, 15(3), 1023-1032.
[http://dx.doi.org/10.1021/acs.jproteome.5b01091] [PMID: 26860878]
[93]
Cheng, W.C.; Chung, I.F.; Chen, C.Y.; Sun, H.J.; Fen, J.J.; Tang, W.C.; Chang, T.Y.; Wong, T.T.; Wang, H.W.; Driver, D.B.; Driver, D.B. An exome sequencing database for cancer driver gene identification. Nucleic Acids Res., 2014, 42(D1), D1048-D1054.
[http://dx.doi.org/10.1093/nar/gkt1025] [PMID: 24214964]
[94]
Barretina, J.; Caponigro, G.; Stransky, N.; Venkatesan, K.; Margolin, A.A.; Kim, S.; Wilson, C.J.; Lehár, J.; Kryukov, G.V.; Sonkin, D.; Reddy, A.; Liu, M.; Murray, L.; Berger, M.F.; Monahan, J.E.; Morais, P.; Meltzer, J.; Korejwa, A.; Jané-Valbuena, J.; Mapa, F.A.; Thibault, J.; Bric-Furlong, E.; Raman, P.; Shipway, A.; Engels, I.H.; Cheng, J.; Yu, G.K.; Yu, J.; Aspesi, P., Jr; de Silva, M.; Jagtap, K.; Jones, M.D.; Wang, L.; Hatton, C.; Palescandolo, E.; Gupta, S.; Mahan, S.; Sougnez, C.; Onofrio, R.C.; Liefeld, T.; MacConaill, L.; Winckler, W.; Reich, M.; Li, N.; Mesirov, J.P.; Gabriel, S.B.; Getz, G.; Ardlie, K.; Chan, V.; Myer, V.E.; Weber, B.L.; Porter, J.; Warmuth, M.; Finan, P.; Harris, J.L.; Meyerson, M.; Golub, T.R.; Morrissey, M.P.; Sellers, W.R.; Schlegel, R.; Garraway, L.A. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature, 2012, 483(7391), 603-607.
[http://dx.doi.org/10.1038/nature11003] [PMID: 22460905]
[95]
Cerami, E.; Gao, J.; Dogrusoz, U.; Gross, B.E.; Sumer, S.O.; Aksoy, B.A.; Jacobsen, A.; Byrne, C.J.; Heuer, M.L.; Larsson, E.; Antipin, Y.; Reva, B.; Goldberg, A.P.; Sander, C.; Schultz, N. The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov., 2012, 2(5), 401-404.
[http://dx.doi.org/10.1158/2159-8290.CD-12-0095] [PMID: 22588877]
[96]
Prior, F.; Smith, K.; Sharma, A.; Kirby, J.; Tarbox, L.; Clark, K.; Bennett, W.; Nolan, T.; Freymann, J. The public cancer radiology imaging collections of the cancer imaging archive. Sci. Data, 2017, 4(1), 170124.
[http://dx.doi.org/10.1038/sdata.2017.124] [PMID: 28925987]
[97]
Gentleman, R.C.; Carey, V.J.; Bates, D.M.; Bolstad, B.; Dettling, M.; Dudoit, S.; Ellis, B.; Gautier, L.; Ge, Y.; Gentry, J.; Hornik, K.; Hothorn, T.; Huber, W.; Iacus, S.; Irizarry, R.; Leisch, F.; Li, C.; Maechler, M.; Rossini, A.J.; Sawitzki, G.; Smith, C.; Smyth, G.; Tierney, L.; Yang, J.Y.H.; Zhang, J. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol., 2004, 5(10), R80.
[http://dx.doi.org/10.1186/gb-2004-5-10-r80] [PMID: 15461798]
[98]
Jalili, V.; Afgan, E.; Gu, Q.; Clements, D.; Blankenberg, D.; Goecks, J.; Taylor, J.; Nekrutenko, A. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2020 update. Nucleic Acids Res., 2020, 48(W1), W395-W402.
[http://dx.doi.org/10.1093/nar/gkaa434] [PMID: 32479607]
[99]
Wadapurkar, R.M.; Vyas, R. Computational analysis of next generation sequencing data and its applications in clinical oncology. Inform. Med. Unlocked, 2018, 11, 75-82.
[http://dx.doi.org/10.1016/j.imu.2018.05.003]
[100]
Ma, R.; Gong, J.; Jiang, X. Novel applications of next-generation sequencing in breast cancer research. Genes Dis., 2017, 4(3), 149-153.
[http://dx.doi.org/10.1016/j.gendis.2017.07.003] [PMID: 30258916]
[101]
Tripathi, R.; Sharma, P.; Chakraborty, P.; Varadwaj, P.K. Next-generation sequencing revolution through big data analytics. Front. Life Sci., 2016, 9(2), 119-149.
[http://dx.doi.org/10.1080/21553769.2016.1178180]
[102]
Patel, R.K.; Jain, M. NGS QC Toolkit: A toolkit for quality control of next generation sequencing data. PLoS One, 2012, 7(2), e30619.
[http://dx.doi.org/10.1371/journal.pone.0030619] [PMID: 22312429]
[103]
Chaitankar, V.; Karakülah, G.; Ratnapriya, R.; Giuste, F.O.; Brooks, M.J.; Swaroop, A. Next generation sequencing technology and genomewide data analysis: Perspectives for retinal research. Prog. Retin. Eye Res., 2016, 55, 1-31.
[http://dx.doi.org/10.1016/j.preteyeres.2016.06.001] [PMID: 27297499]
[104]
Hempel, D.; Ebner, F.; Garg, A.; Trepotec, Z.; Both, A.; Stein, W.; Gaumann, A.; Güttler, L.; Janni, W.; DeGregorio, A.; Hempel, L.; Milani, V. Real world data analysis of next generation sequencing and protein expression in metastatic breast cancer patients. Sci. Rep., 2020, 10(1), 10459.
[http://dx.doi.org/10.1038/s41598-020-67393-9] [PMID: 32591580]
[105]
Nones, K.; Patch, A.M. The impact of next generation sequencing in cancer research. Cancers (Basel), 2020, 12(10), 2928.
[http://dx.doi.org/10.3390/cancers12102928] [PMID: 33053644]
[106]
Tsai, H.P.; Huang, S.F.; Li, C.F.; Chien, H.T.; Chen, S.C. Differential microRNA expression in breast cancer with different onset age. PLoS One, 2018, 13(1), e0191195.
[http://dx.doi.org/10.1371/journal.pone.0191195] [PMID: 29324832]
[107]
Jeibouei, S.; Akbari, M.E.; Kalbasi, A.; Aref, A.; Ajoudanian, M.; Rezvani, A.; Zali, H. Personalized medicine in breast cancer: Pharmacogenomics approaches. Pharm. Genomics Pers. Med., 2019, 12, 59-73.
[http://dx.doi.org/10.2147/PGPM.S167886] [PMID: 31213877]
[108]
Cirillo, D.; Valencia, A. Big data analytics for personalized medicine. Curr. Opin. Biotechnol., 2019, 58, 161-167.
[http://dx.doi.org/10.1016/j.copbio.2019.03.004] [PMID: 30965188]
[109]
Matsui, S. Genomic biomarkers for personalized medicine: Development and validation in clinical studies. Comput. Math. Methods Med., 2013, 2013, 865980.
[http://dx.doi.org/10.1155/2013/865980] [PMID: 23690882]
[110]
Suwinski, P.; Ong, C.; Ling, M.H.T.; Poh, Y.M.; Khan, A.M.; Ong, H.S. Advancing personalized medicine through the application of whole exome sequencing and big data analytics. Front. Genet., 2019, 10, 49.
[http://dx.doi.org/10.3389/fgene.2019.00049] [PMID: 30809243]
[111]
Ke, X.; Shen, L. Molecular targeted therapy of cancer: The progress and future prospect. Frontiers in Laboratory Medicine, 2017, 1(2), 69-75.
[http://dx.doi.org/10.1016/j.flm.2017.06.001]
[112]
Vyas, R.; Bapat, S.; Jain, E.; Tambe, S.S.; Karthikeyan, M.; Kulkarni, B.D. A study of applications of machine learning based classification methods for virtual screening of lead molecules. Comb. Chem. High Throughput Screen., 2015, 18(7), 658-672.
[http://dx.doi.org/10.2174/1386207318666150703112447] [PMID: 26138573]
[113]
Kourou, K.; Exarchos, T.P.; Exarchos, K.P.; Karamouzis, M.V.; Fotiadis, D.I. Machine learning applications in cancer prognosis and prediction. Comput. Struct. Biotechnol. J., 2015, 13, 8-17.
[http://dx.doi.org/10.1016/j.csbj.2014.11.005] [PMID: 25750696]
[114]
Tufail, A.B.; Ma, Y.K.; Kaabar, M.K.A.; Martínez, F.; Junejo, A.R.; Ullah, I.; Khan, R. Deep learning in cancer diagnosis and prognosis prediction: a minireview on challenges, recent trends, and future directions. Comput. Math. Methods Med., 2021, 2021, 9025470.
[http://dx.doi.org/10.1155/2021/9025470] [PMID: 34754327]
[115]
Schneider, L.; Laiouar-Pedari, S.; Kuntz, S.; Krieghoff-Henning, E.; Hekler, A.; Kather, J.N.; Gaiser, T.; Fröhling, S.; Brinker, T.J. Integration of deep learning-based image analysis and genomic data in cancer pathology: A systematic review. Eur. J. Cancer, 2022, 160, 80-91.
[http://dx.doi.org/10.1016/j.ejca.2021.10.007] [PMID: 34810047]
[116]
Tran, K.A.; Kondrashova, O.; Bradley, A.; Williams, E.D.; Pearson, J.V.; Waddell, N. Deep learning in cancer diagnosis, prognosis and treatment selection. Genome Med., 2021, 13(1), 152.
[http://dx.doi.org/10.1186/s13073-021-00968-x] [PMID: 34579788]
[117]
Vyas, R.; Bapat, S.; Jain, E.; Karthikeyan, M.; Tambe, S.; Kulkarni, B.D. Building and analysis of protein-protein interactions related to diabetes mellitus using support vector machine, biomedical text mining and network analysis. Comput. Biol. Chem., 2016, 65, 37-44.
[http://dx.doi.org/10.1016/j.compbiolchem.2016.09.011] [PMID: 27744173]
[118]
Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N.S.; Wang, J.T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res., 2003, 13(11), 2498-2504.
[http://dx.doi.org/10.1101/gr.1239303] [PMID: 14597658]
[119]
Lv, C.; Huang, Y.; Huang, R.; Wang, Q.; Zhang, H.; Jin, J.; Lu, D.; Zhou, Y.; Shen, Y.; Zhang, W.; Luan, X.; Liu, S. Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells. Mol. Ther. Oncolytics, 2022, 24, 340-354.
[http://dx.doi.org/10.1016/j.omto.2021.12.025] [PMID: 35118192]
[120]
Moon, S.Y.; Lee, H.; Kim, S.; Hong, J.H.; Chun, S.H.; Lee, H.Y.; Kang, K.; Kim, H.S.; Won, H.S.; Ko, Y.H. Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells. BMC Cancer, 2021, 21(1), 931.
[http://dx.doi.org/10.1186/s12885-021-08641-7] [PMID: 34407787]
[121]
Zhong, P.; Hua, H.; Chen, S.; Zhu, Z.; Xie, F. The prognostic value of lncRNA AGAP2-AS1 in cancer patients. Medicine (Baltimore), 2021, 100(51), e28425.
[http://dx.doi.org/10.1097/MD.0000000000028425] [PMID: 34941192]
[122]
Zhou, D.; Gu, J.; Wang, Y.; Luo, B.; Feng, M.; Wang, X. Long noncoding RNA CCAT2 reduces chemosensitivity to 5‐fluorouracil in breast cancer cells by activating the mTOR axis. J. Cell. Mol. Med., 2022, 26(5), 1392-1401.
[http://dx.doi.org/10.1111/jcmm.17041] [PMID: 35170195]
[123]
Abba, M.C.; Fabre, M.L.; Lee, J.; Tatineni, P.; Kil, H.; Aldaz, C.M. HOTAIR Modulated Pathways in Early-Stage Breast Cancer Progression. Front. Oncol., 2021, 11, 783211.
[http://dx.doi.org/10.3389/fonc.2021.783211] [PMID: 34869037]
[124]
Gu, J.; Wang, Y.; Wang, X.; Zhou, D.; Shao, C.; Zhou, M.; He, Z. Retraction notice to “Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer”. [Canc. Lett. 434 (2018) 1–10]. Cancer Lett., 2021, 517, 106.
[http://dx.doi.org/10.1016/j.canlet.2021.07.004] [PMID: 34274167]
[125]
Mansoori, Y.; Tabei, M.B.; Askari, A.; Izadi, P.; Daraei, A.; Bastami, M.; Naghizadeh, M.M.; Nariman-Saleh-Fam, Z.; Mansoori, B.; Tavakkoly-Bazzaz, J. Expression levels of breast cancer-related GAS5 and LSINCT5 lncRNAs in cancer-free breast tissue: Molecular associations with age at menarche and obesity. Breast J., 2018, 24(6), 876-882.
[http://dx.doi.org/10.1111/tbj.13067] [PMID: 29785740]
[126]
Deng, J.; Liu, M.; Xiao, R.; Wang, J.; Liao, X.; Ye, Z.; Sun, Z. Risk, incidence, and mortality of breast cancer in primary sjögren’s syndrome: A systematic review and meta-analysis. Front. Immunol., 2022, 13, 904682.
[http://dx.doi.org/10.3389/fimmu.2022.904682] [PMID: 35844507]
[127]
Nabet, B.Y.; Qiu, Y.; Shabason, J.E.; Wu, T.J.; Yoon, T.; Kim, B.C.; Benci, J.L.; DeMichele, A.M.; Tchou, J.; Marcotrigiano, J.; Minn, A.J. Exosome RNA unshielding couples stromal activation to pattern recognition receptor signaling in cancer. Cell, 2017, 170(2), 352-366.e13.
[http://dx.doi.org/10.1016/j.cell.2017.06.031] [PMID: 28709002]
[128]
Xie, S-D.; Qin, C.; Jin, L-D.; Wang, Q-C.; Shen, J.; Zhou, J-C.; Chen, Y-X.; Huang, A-H.; Zhao, W-H.; Wang, L-B. Long noncoding RNA SNHG14 promotes breast cancer cell proliferation and invasion via sponging miR-193a-3p. Eur. Rev. Med. Pharmacol. Sci., 2020, 24(14), 7543.
[PMID: 32744648]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy
Request history8.2.27PHP Version366msRequest Duration28MBMemory UsageGET article/{article_id}/{param?}Route
  • warninglog[20:36:33] LOG.warning: Optional parameter $article_id declared before required parameter $request i...
  • warninglog[20:36:34] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • warninglog[20:36:34] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[20:36:34] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • Booting (135ms)time
  • Application (231ms)time
  • 1 x Application (63.06%)
    231ms
    1 x Booting (36.94%)
    135ms
    14 templates were rendered
    • articlearticle.blade.php#?blade
    • includes.article_top_bannerarticle_top_banner.blade.php#?blade
    • includes.article_referencearticle_reference.blade.php#?blade
    • export_citation_formexport_citation_form.blade.php#?blade
    • includes.article_bottom_bannerarticle_bottom_banner.blade.php#?blade
    • includes.inc_related_journalsinc_related_journals.blade.php#?blade
    • includes.inc_related_ebooksinc_related_ebooks.blade.php#?blade
    • includes.journal_rightmenujournal_rightmenu.blade.php#?blade
    • includes.journal_right_bannerjournal_right_banner.blade.php#?blade
    • layouts.appapp.blade.php#?blade
    • layouts._login_access_login_access.blade.php#?blade
    • layouts._header_header.blade.php#?blade
    • layouts._main_menu_main_menu.blade.php#?blade
    • layouts._footer_menu_footer_menu.blade.php#?blade
    uri
    GET article/{article_id}/{param?}
    middleware
    web, check_user_access
    controller
    App\Http\Controllers\ArticleController@GetArticleDetails
    namespace
    App\Http\Controllers
    where
    as
    article
    file
    app/Http/Controllers/ArticleController.php:1974-2510
    36 statements were executed, 4 of which were duplicates, 32 unique. Show only duplicated134ms
    • Connection Establishedalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 9. middleware::check_user_access:24
      • 10. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 11. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address (ip_address,visitor_agent,visitor_count, created_on,updated_on) VALUES ('59228343','',1,1740515793,1740515793) ON DUPLICATE KEY UPDATE visitor_count=visitor_count + 1, updated_on=1740515793
      1.22msalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 11. middleware::check_user_access:24
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address_detail (ip_address,visitor_url,visitor_count, created_on,updated_on) VALUES ('59228343','/article/126191',1,1740515793,1740515793)
      160μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#27
      Backtrace
      • 11. middleware::check_user_access:27
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_trail WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_corporate WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_token WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_trail WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_corporate WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_token WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_trail WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_corporate WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_token WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_trail WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_corporate WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_token WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_trail WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_corporate WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_token WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_disease_corporate WHERE to_ip >= 59228343 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59228343) limit 1
      16.25msalphaeurekaselec_live_10_06_2022UserAccess.php#784
      Bindings
      • 0: 59228343
      • 1: 59228343
      • 2: 59228343
      • 3: 59228343
      • 4: 59228343
      • 5: 59228343
      • 6: 59228343
      • 7: 59228343
      • 8: 59228343
      • 9: 59228343
      • 10: 59228343
      • 11: 59228343
      • 12: 59228343
      • 13: 59228343
      • 14: 59228343
      • 15: 59228343
      Backtrace
      • 14. app/Models/UserAccess/UserAccess.php:784
      • 15. middleware::check_user_access:114
      • 16. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 18. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
    • SELECT at.type_name, p.copyright, p.publisher_location,m.month,y.year, a.publish_on, a.nid article_nid,a.article_id, a.pmid, a.issue_id, a.title, a.abstract,a.podcast,a.altmetric_score,a.altmetric_url,a.kudos_url, a.page_count, a.first_page, a.elocator, a.last_page, i.publication_date, a.file_name, a.file_path, a.doi, a.is_epub,a.epub_type, a.volume_id, a.is_uploaded, a.editor_choice, a.is_epub, j.image_file_name, a.article_no, a.art_type AS article_type, a.supplementary_filename,a.html_filename,a.prc_filename,a.epub_filename, a.graph_abs_lg_filename, a.graph_abs_sm_filename, a.oa_image_lg_filename, a.oa_image_sm_filename, j.journal_banner,a.animated_abstract,a.erratum_in,a.erratum_for, (CASE WHEN a.issue_id =0 THEN j.epub_price ELSE j.price END) AS sell_price, j.epub_price, j.nid AS jour_nid, j.title AS journal_title, j.issn, j.eissn,j.journal_id, j.subtitle AS jour_subtitle, v.volume_id,v.volume_name AS volume, v.year_id, i.title AS issue, i.month_id ,i.type issue_type, j.subtitle,j.formerly_title, ac.subtitle AS epub_title,a.crossmark_enabled,a.text_mining_urls,a.license_urls,a.created, a.receivedate, a.revisedate, a.acceptdate,js.js_title FROM article a LEFT JOIN article_section ac ON a.is_epub = ac.art_sec_id LEFT JOIN journal_section js ON a.js_id = js.js_id LEFT JOIN article_type at ON a.art_type = at.art_type_id LEFT JOIN issue i ON a.issue_id = i.issue_id LEFT JOIN month m ON m.id = i.month_id LEFT JOIN volume v ON v.volume_id = a.volume_id INNER JOIN year y ON y.id = v.year_id INNER JOIN journal j ON j.journal_id = a.journal_id INNER JOIN publisher p ON p.publisher_id = j.publisher_id WHERE a.article_id=126191
      920μsalphaeurekaselec_live_10_06_2022Article.php#408
      Backtrace
      • 11. app/Models/Article.php:408
      • 12. app/Http/Controllers/ArticleController.php:2515
      • 13. app/Http/Controllers/ArticleController.php:2035
      • 14. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 15. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `journal` where `journal_id` = 38 limit 1
      1.03msalphaeurekaselec_live_10_06_2022Journal.php#64
      Bindings
      • 0: 38
      Backtrace
      • 14. app/Models/Journal.php:64
      • 15. app/Http/Controllers/ArticleController.php:2516
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=38) and sj.journal_id!=38 group by `j`.`nid`) as `aggregate_table`
      1.62msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 16. app/Models/Subject.php:200
      • 17. app/Http/Controllers/ArticleController.php:2517
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=38) and sj.journal_id!=38 group by `j`.`nid` order by `j`.`journal_id` asc limit 10 offset 0
      1.3msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 14. app/Models/Subject.php:200
      • 15. app/Http/Controllers/ArticleController.php:2517
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=38) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid`) as `aggregate_table`
      2.2msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 16. app/Models/Subject.php:220
      • 17. app/Http/Controllers/ArticleController.php:2518
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=38) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid` order by `v`.`ebook_volume_id` desc limit 10 offset 0
      1.86msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 14. app/Models/Subject.php:220
      • 15. app/Http/Controllers/ArticleController.php:2518
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `keywords` where `article_id` = '126191'
      1.31msalphaeurekaselec_live_10_06_2022Keywords.php#43
      Bindings
      • 0: 126191
      Backtrace
      • 13. app/Models/Keywords.php:43
      • 14. app/Http/Controllers/ArticleController.php:2519
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `article_citation` where `article_id` = '126191'
      6.33msalphaeurekaselec_live_10_06_2022Article.php#1570
      Bindings
      • 0: 126191
      Backtrace
      • 13. app/Models/Article.php:1570
      • 14. app/Http/Controllers/ArticleController.php:2520
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select CONCAT_WS(' ',au.first_name, ' ', ifnull(au.initials,''), ' ', au.last_name) as authors, CONCAT(au.last_name, IFNULL(CONCAT(' ', au.initials), ''), ' ', au.first_name) AS authorsRIS, CONCAT_WS(' ',au.last_name, ' ', ifnull(au.initials,''), ' ', au.first_name) as authorsCiteAs, CONCAT_WS(' ',au.first_name, IFNULL(CONCAT(' ', au.initials), ''), IFNULL(CONCAT(' ', au.last_name), '')) as authorsmodal , `au`.*, `af`.`ror_id`, `af`.`institution`, `af`.`department`, `af`.`country`, `af`.`city`, `af`.`address`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.institution,','),''), ifnull(concat(af.department,','),''), ifnull(concat(af.address,','),''), ifnull(concat(af.city,','),''), ifnull(concat(af.country,','),''), ifnull(concat(af.postal_code,','),''), ifnull(concat(af.phone,','),''), ifnull(concat(af.fax,','),''))) SEPARATOR '|')) as `author_affiliation`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.web_view,','),''))) SEPARATOR '|')) as `web_view` from `author` as `au` left join `author_affiliation` as `af` on `au`.`author_id` = `af`.`author_id` where `au`.`article_id` = '126191' group by `au`.`author_id` order by `au`.`article_id` asc, `au`.`sequence` asc
      1.71msalphaeurekaselec_live_10_06_2022Author.php#86
      Bindings
      • 0: 126191
      Backtrace
      • 13. app/Models/Author.php:86
      • 14. app/Http/Controllers/ArticleController.php:2533
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      250μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2535
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `subtitle` from `journal` where `continues_publication_journal` = 1
      490μsalphaeurekaselec_live_10_06_2022Article.php#1960
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/Article.php:1960
      • 14. app/Http/Controllers/ArticleController.php:2062
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • Select j.subtitle, v.volume_id as volume_id,v.year_id,y.year as year,v.volume_name, v.total_no_of_issues, i.issue_id as issue_id,i.title as issue, i.publication_date as issue_pub_date from journal j join volume v on j.journal_id = v.journal_id join issue i on v.volume_id = i.volume_id join article a on a.issue_id = i.issue_id join year y on v.year_id = y.id where j.journal_id = 38 and i.is_uploaded = 1 order by v.volume_name+0 desc, i.title+0 desc limit 1
      49.06msalphaeurekaselec_live_10_06_2022Issue.php#298
      Backtrace
      • 11. app/Models/Issue.php:298
      • 12. app/Http/Controllers/ArticleController.php:2068
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 1 and a.journal_id = 38 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      18.98msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2070
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 4 and a.journal_id = 38 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      15.73msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2071
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select pdf, html, epub, prc from `article_metrics` where `article_id` = 126191 limit 1
      260μsalphaeurekaselec_live_10_06_2022Article.php#744
      Bindings
      • 0: 126191
      Backtrace
      • 14. app/Models/Article.php:744
      • 15. app/Http/Controllers/ArticleController.php:2091
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from content_by_diseases where content_id = 126191 and content_type = 'article' order by status desc limit 1
      290μsalphaeurekaselec_live_10_06_2022Article.php#751
      Backtrace
      • 11. app/Models/Article.php:751
      • 12. app/Http/Controllers/ArticleController.php:2094
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `node_meta` where `nid` = 208604 limit 1
      240μsalphaeurekaselec_live_10_06_2022Meta.php#30
      Bindings
      • 0: 208604
      Backtrace
      • 14. app/Models/Meta.php:30
      • 15. app/Http/Controllers/ArticleController.php:2101
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      240μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2108
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `tbl_ht_submission` as `h` where `h`.`subtitle` = 'CTMC' and (h.proposal_closing_date = 0 OR TO_DAYS(FROM_UNIXTIME(h.proposal_closing_date)) >= TO_DAYS(NOW())) order by `h`.`manuscript` asc
      360μsalphaeurekaselec_live_10_06_2022Article.php#2025
      Bindings
      • 0: CTMC
      Backtrace
      • 13. app/Models/Article.php:2025
      • 14. app/Http/Controllers/ArticleController.php:2112
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '126191' and content_type = 'a' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      360μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2186
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '11871' and content_type = 'i' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      360μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2207
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '3201' and content_type = 'v' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      310μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2231
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59228343 and j.to_ip >=59228343 )) and ((j.from_date <= 1740515794 and j.to_date >= 1740515794 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 3201) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59228343 and j.to_ip >=59228343 )) and ((j.from_date <= 1740515794 and j.to_date >= 1740515794 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 3201) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59228343 and j.to_ip >=59228343 )) and ((j.from_date <= 1740515794 and j.to_date >= 1740515794 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 3201)
      4.36msalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2272
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59228343 and j.to_ip >=59228343 )) and ((j.from_date <= 1740515794 and j.to_date >= 1740515794 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 11871) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59228343 and j.to_ip >=59228343 )) and ((j.from_date <= 1740515794 and j.to_date >= 1740515794 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 11871) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59228343 and j.to_ip >=59228343 )) and ((j.from_date <= 1740515794 and j.to_date >= 1740515794 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 11871)
      580μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2297
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59228343 and j.to_ip >=59228343 )) and ((j.from_date <= 1740515794 and j.to_date >= 1740515794 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 126191) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59228343 and j.to_ip >=59228343 )) and ((j.from_date <= 1740515794 and j.to_date >= 1740515794 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 126191) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59228343 and j.to_ip >=59228343 )) and ((j.from_date <= 1740515794 and j.to_date >= 1740515794 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 126191)
      640μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2329
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `first_page` < '1793' and is_uploaded = 1 and issue_id = 11871 order by cast(first_page as SIGNED) desc limit 1
      510μsalphaeurekaselec_live_10_06_2022Article.php#1819
      Bindings
      • 0: 1793
      Backtrace
      • 14. app/Models/Article.php:1819
      • 15. app/Http/Controllers/ArticleController.php:2470
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `last_page` > '1810' and is_uploaded = 1 and issue_id = 11871 order by cast(first_page as SIGNED) asc limit 1
      390μsalphaeurekaselec_live_10_06_2022Article.php#1831
      Bindings
      • 0: 1810
      Backtrace
      • 14. app/Models/Article.php:1831
      • 15. app/Http/Controllers/ArticleController.php:2472
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `language_id` from `multilanguage` where `short_code` = 'en'
      180μsalphaeurekaselec_live_10_06_2022ArticleController.php#2497
      Bindings
      • 0: en
      Backtrace
      • 14. app/Http/Controllers/ArticleController.php:2497
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `source_lang_label`, `target_lang_label` from `multilanguage_labels` where `target_lang_id` = 1
      190μsalphaeurekaselec_live_10_06_2022MultiLanguage.php#23
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/MultiLanguage.php:23
      • 14. app/Http/Controllers/ArticleController.php:2498
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `id` from `multilanguage_article` where `article_id` = 126191 limit 1
      2.3msalphaeurekaselec_live_10_06_2022ArticleController.php#2506
      Bindings
      • 0: 126191
      Backtrace
      • 16. app/Http/Controllers/ArticleController.php:2506
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 20. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 38 and `b`.`banner_from_date` <= 1740515794 and `b`.`banner_to_date` >= 1740515794 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.11msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 38
      • 3: 1740515794
      • 4: 1740515794
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 38 and `b`.`banner_from_date` <= 1740515794 and `b`.`banner_to_date` >= 1740515794 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.06msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 38
      • 3: 1740515794
      • 4: 1740515794
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select count(*) as aggregate from `uc_cart_products` where cart_id='afaf646f22c67aa049f509cba6d152cb'
      210μsalphaeurekaselec_live_10_06_2022Cart.php#271
      Backtrace
      • 15. app/Models/Cart.php:271
      • 16. view::layouts._header:260
      • 18. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 20. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    App\Models\MultiLanguage
    1MultiLanguage.php#?
        _token
        5b4Yn06mVMAey11rTTDEjkRnEZDeUqbn0ZA2WNUE
        uc_cart_id
        afaf646f22c67aa049f509cba6d152cb
        _previous
        array:1 [ "url" => "http://alpha.eurekaselect.com/article/126191" ]
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /article/126191
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:9 [ "cookie" => array:1 [ 0 => "wayfindertarget=eyJpdiI6IjcyZDhPVjBaSGJpc2haTEllOWEwZ1E9PSIsInZhbHVlIjoiUlFEbnVlWkFNN1lRREZOVngxSityR0RWeU9LaitUa2gwQXJuZzFadkExaz0iLCJtYWMiOiJhZTdiNWEzZmY2MjE4YTYzNTRjNjllMWRkOWM3YmI3OTgzMzE0ZjAwMTBmODRiMmZjOThlOWYzM2FmNDE5NmE3IiwidGFnIjoiIn0%3Dwayfindertarget=eyJpdiI6IjcyZDhPVjBaSGJpc2haTEllOWEwZ1E9PSIsInZhbHVlIjoiUlFEbnVlWkFNN1lRREZOVngxSityR0RWeU9LaitUa2gwQXJuZzFadkExaz0iLCJtYWMiOiJhZTdiNWEzZmY2MjE4" ] "accept-encoding" => array:1 [ 0 => "gzip, deflate" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "alpha.eurekaselect.com" ] ]
        request_cookies
        0 of 0
        array:1 [ "wayfindertarget" => null ]
        response_headers
        0 of 0
        array:5 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Tue, 25 Feb 2025 20:36:34 GMT" ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6Im0wRVN6eHZtVTNXWjJKTWQ5MFRqMXc9PSIsInZhbHVlIjoiRWRFWk1VVUZVUTVZTEhKSk5KSGpVUzJRbkJOaVdMYUwyb3RYRGJ0UzBiaUVIaTJWM1FCMWJiaFUrWE51ZkVXV09oNnZDMDFsckl3dWFiaDhWWTh3TjFVaHhGaTBmckg0OCtQWVhOZTdLWmdPZ2NmY0o2elM5OXpFMnBURlI1MVAiLCJtYWMiOiIzZTRiNDM2YzI1ZWYzMDRkOGI5NTUzYjVhMDBhYWEyMjdjYjQxNGI5NTAwYmI5NjQyNzBlNzE4YTg5NTA5MTY2IiwidGFnIjoiIn0%3D; expires=Fri, 28 Feb 2025 08:36:34 GMT; Max-Age=216000; path=/; secure; samesite=laxXSRF-TOKEN=eyJpdiI6Im0wRVN6eHZtVTNXWjJKTWQ5MFRqMXc9PSIsInZhbHVlIjoiRWRFWk1VVUZVUTVZTEhKSk5KSGpVUzJRbkJOaVdMYUwyb3RYRGJ0UzBiaUVIaTJWM1FCMWJiaFUrWE51ZkVXV09oNnZDM" 1 => "alphaeurekaselectnet_session=eyJpdiI6IlRWakFVR1E2blNQaW8wZlpQUm5PR0E9PSIsInZhbHVlIjoiSjgycXdzdEJaZkpFbGtKMitoa0VyQUdmNlVzOHpCZEtEb1V0bDZrVVFySHVMdE1seFpMRUI1WGp5RVVheXpBaEkvdVlUekJMSldFcm9kQVRBMFNZTi84TDd2Z1l6S2pVMTkyK2M5WTZ3NkVOb0lVOEhpTG1BM3lpQVlMVmIxamQiLCJtYWMiOiI5MDk1NTliOThmZDQyZGMwYzhiN2VlMjY4YmRmZGU1ODc5MzFmYTZjMGZjYzI5MDEzZDcyMmMzMzBlMTE1NjZiIiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=laxalphaeurekaselectnet_session=eyJpdiI6IlRWakFVR1E2blNQaW8wZlpQUm5PR0E9PSIsInZhbHVlIjoiSjgycXdzdEJaZkpFbGtKMitoa0VyQUdmNlVzOHpCZEtEb1V0bDZrVVFySHVMdE1seFpMRUI1WGp" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6Im0wRVN6eHZtVTNXWjJKTWQ5MFRqMXc9PSIsInZhbHVlIjoiRWRFWk1VVUZVUTVZTEhKSk5KSGpVUzJRbkJOaVdMYUwyb3RYRGJ0UzBiaUVIaTJWM1FCMWJiaFUrWE51ZkVXV09oNnZDMDFsckl3dWFiaDhWWTh3TjFVaHhGaTBmckg0OCtQWVhOZTdLWmdPZ2NmY0o2elM5OXpFMnBURlI1MVAiLCJtYWMiOiIzZTRiNDM2YzI1ZWYzMDRkOGI5NTUzYjVhMDBhYWEyMjdjYjQxNGI5NTAwYmI5NjQyNzBlNzE4YTg5NTA5MTY2IiwidGFnIjoiIn0%3D; expires=Fri, 28-Feb-2025 08:36:34 GMT; path=/; secureXSRF-TOKEN=eyJpdiI6Im0wRVN6eHZtVTNXWjJKTWQ5MFRqMXc9PSIsInZhbHVlIjoiRWRFWk1VVUZVUTVZTEhKSk5KSGpVUzJRbkJOaVdMYUwyb3RYRGJ0UzBiaUVIaTJWM1FCMWJiaFUrWE51ZkVXV09oNnZDM" 1 => "alphaeurekaselectnet_session=eyJpdiI6IlRWakFVR1E2blNQaW8wZlpQUm5PR0E9PSIsInZhbHVlIjoiSjgycXdzdEJaZkpFbGtKMitoa0VyQUdmNlVzOHpCZEtEb1V0bDZrVVFySHVMdE1seFpMRUI1WGp5RVVheXpBaEkvdVlUekJMSldFcm9kQVRBMFNZTi84TDd2Z1l6S2pVMTkyK2M5WTZ3NkVOb0lVOEhpTG1BM3lpQVlMVmIxamQiLCJtYWMiOiI5MDk1NTliOThmZDQyZGMwYzhiN2VlMjY4YmRmZGU1ODc5MzFmYTZjMGZjYzI5MDEzZDcyMmMzMzBlMTE1NjZiIiwidGFnIjoiIn0%3D; path=/; secure; httponlyalphaeurekaselectnet_session=eyJpdiI6IlRWakFVR1E2blNQaW8wZlpQUm5PR0E9PSIsInZhbHVlIjoiSjgycXdzdEJaZkpFbGtKMitoa0VyQUdmNlVzOHpCZEtEb1V0bDZrVVFySHVMdE1seFpMRUI1WGp" ] ]
        session_attributes
        0 of 0
        array:5 [ "_token" => "5b4Yn06mVMAey11rTTDEjkRnEZDeUqbn0ZA2WNUE" "uc_cart_id" => "afaf646f22c67aa049f509cba6d152cb" "_previous" => array:1 [ "url" => "http://alpha.eurekaselect.com/article/126191" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]
        ClearShow all
        Date ↕MethodURLData
        #12025-02-25 20:36:34GET/article/126191414361